Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
Arizona, broad, Center, circulating, commonly, conference, daily, differentiation, diverse, DNA, domain, DOR, driven, durability, Durable, Eradication, Evidence, exhibited, exposure, extracellular, fifty, gadolinium, glioma, group, intracranial, Ivy, MAPK, mediated, military, opportunity, oral, overcome, pathway, Phoenix, President, proliferation, recurrent, reduction, regression, resection, reversible, showed, showing, shown, spanning, spectrum, sponsored, strong, suggesting, surgery, survival, variant, window, xenograft
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view